164 related articles for article (PubMed ID: 26245994)
1. Staphylococcal enterotoxin B/texosomes as a candidate for breast cancer immunotherapy.
Imani Fooladi AA; Halabian R; Mahdavi M; Amin M; Mahmoodzadeh Hosseini H
Tumour Biol; 2016 Jan; 37(1):739-48. PubMed ID: 26245994
[TBL] [Abstract][Full Text] [Related]
2. Tagging staphylococcal enterotoxin B (SEB) with TGFaL3 for breast cancer therapy.
Yousefi F; Siadat SD; Saraji AA; Hesaraki S; Aslani MM; Mousavi SF; Imani Fooladi AA
Tumour Biol; 2016 Apr; 37(4):5305-16. PubMed ID: 26561468
[TBL] [Abstract][Full Text] [Related]
3. Texosome-anchored superantigen triggers apoptosis in original ovarian cancer cells.
Mahmoodzadeh Hosseini H; Soleimanirad J; Mehdizadeh Aghdam E; Amin M; Imani Fooladi AA
Med Oncol; 2015 Jan; 32(1):409. PubMed ID: 25452173
[TBL] [Abstract][Full Text] [Related]
4. Construction and characterization of a novel superantigen fusion protein: bFGF/SEB.
Wang L; Zhang H; Zhang S; Yu M; Yang X
Cancer Invest; 2009 May; 27(4):376-83. PubMed ID: 19160106
[TBL] [Abstract][Full Text] [Related]
5. Unique cytokine production profile of anergic human T cells in SCID-hu mice after staphylococcal enterotoxin B administration.
Schols D; Jones D; Roncarolo MG
J Immunol; 1995 Apr; 154(7):3204-12. PubMed ID: 7534791
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells.
Shimizu M; Yamamoto A; Nakano H; Matsuzawa A
Cancer Res; 1996 Aug; 56(16):3731-6. PubMed ID: 8706016
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model.
Woody MA; Krakauer T; Stiles BG
Vaccine; 1997 Feb; 15(2):133-9. PubMed ID: 9066029
[TBL] [Abstract][Full Text] [Related]
10. Epicutaneous sensitization with superantigen induces allergic skin inflammation.
Laouini D; Kawamoto S; Yalcindag A; Bryce P; Mizoguchi E; Oettgen H; Geha RS
J Allergy Clin Immunol; 2003 Nov; 112(5):981-7. PubMed ID: 14610492
[TBL] [Abstract][Full Text] [Related]
11. Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors.
Woody MA; Krakauer T; Ulrich RG; Stiles BG
J Infect Dis; 1998 Apr; 177(4):1013-22. PubMed ID: 9534976
[TBL] [Abstract][Full Text] [Related]
12. Preparation and In Vitro Evaluation of Antitumor Activity of TGFαL3-SEB as a Ligand-Targeted Superantigen.
Yousefi F; Mousavi SF; Siadat SD; Aslani MM; Amani J; Rad HS; Fooladi AA
Technol Cancer Res Treat; 2016 Apr; 15(2):215-26. PubMed ID: 25759426
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a recombinant double mutant of staphylococcal enterotoxin B (SEB-H32Q/K173E) with enhanced antitumor activity effects and decreased pyrexia.
Gu L; Yue J; Zheng Y; Zheng X; Wang J; Wang Y; Li J; Jiang Y; Jiang H
PLoS One; 2013; 8(2):e55892. PubMed ID: 23405232
[TBL] [Abstract][Full Text] [Related]
14. Superantigen activation and kinetics of cytokines in the Long-Evans rat.
Huang W; Koller LD
Immunology; 1998 Nov; 95(3):331-8. PubMed ID: 9824494
[TBL] [Abstract][Full Text] [Related]
15. Macrophage cell-derived exosomes/staphylococcal enterotoxin B against fibrosarcoma tumor.
Behzadi E; Hosseini HM; Halabian R; Fooladi AAI
Microb Pathog; 2017 Oct; 111():132-138. PubMed ID: 28843722
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of cellular and cytokine responses in a chimeric mouse model for the study of staphylococcal enterotoxin B pathogenesis.
Yuan L; Lowell GH; Hoover DL; Colleton CA; Hammack CA; Young LD; Fischer R; Patchen ML; Cross AS
Immunol Lett; 2000 Jan; 71(1):19-26. PubMed ID: 10709781
[TBL] [Abstract][Full Text] [Related]
17. Persistent production of TH2-type cytokines and polyclonal B cell activation after chronic administration of staphylococcal enterotoxin B in mice.
Florquin S; Amraoui Z; Goldman M
J Autoimmun; 1996 Oct; 9(5):609-15. PubMed ID: 8933276
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcal enterotoxin B as DNA vaccine against breast cancer in a murine model.
Halabian R; Jahangiri A; Sedighian H; Behzadi E; Fooladi AAI
Int Microbiol; 2023 Nov; 26(4):939-949. PubMed ID: 36991248
[TBL] [Abstract][Full Text] [Related]
19. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U
Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
